Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur zu Kapitel 9
Albers P, Ulbright TM, Albers J et al. (1996) Tumor proliferative activity is predictive of pathological stage in clinical stage A non-seminomatous testicular germ cell tumors. J Urol 155:579–586
Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N, Müller SC (1997) MIB-1 immunohistochemistry predicts patients at low risk of metastasis in clinical stage I nonseminomatous testicular germ cell tumors. Cancer 79:1710–1716
Albers P, Siener R, Kliesch S et al. for the GTCSG and the German Association of Urologic Oncology (2003) Risk factors for relapse in clinical stage I non-seminomatous testicular germ cell tumors (NSGCT). Results of the German Testicular Cancer Study Group (GTCSG) trial. J Clin Oncol 21:1505–1512
Albers P, Albrecht W, Algaba F et al. (2005) European Association of Urology (EAU). Guidelines on testicular cancer. Eur Urol 48:885–894
Albers P, Bokemeyer C, Krege S, Souchon H (2006) Leitlinien zur Diagnostik und Therapie von Hodentumoren. Interdisziplinäre Leitlinien Onkologie der Deutschen Krebsgesellschaft. Zuckschwerdt, München
Aparicio J et al. (1997) International Germ Cell Cancer Collaborative Group: International Germ Cell Consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603
Comiter CV, Benson CJ, Capelouto CC, Kantoff P, Shulman L, Richie JP, Loughlin KR (1995) Nonpalpable intratesticular masses detected sonographically. J Urol 154:1367–1369
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) WHO classification of tumours. Pathology and genetics of the urinary system and male genital organs. IARC, Lyon, pp 218, 250–262
Hamm B (1997) Differential diagnosis of scrotal masses by ultrasound. Eur Radiol 7:668–679
Hilton S, Herr HW, Teitcher JB, Begg CB, Castellino RA (1997) CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. Am J Roentgenol 169:521–525
International Germ Cell Cancer Collaborative Group (1997) International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603
Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP (2005) Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol Feb 20:1200–1208
Krege S, Boergermann C, Baschek R et al. (2006) Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol 17:276–280
Leibovitch I, Foster RS, Kopecky KK, Donohue JP (1995) Improved accuracy of computerized tomography based on clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol 154:1759–1763
Lien HH, Stenwig AE, Ous S, Fossa SD (1986) Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor. Acta Radiol Diagn 27:199–203
Oliver RT, Mason MD, Mead GM et al. (2005) MRC TE19 collaborators and the EORTC 30982 collaborators. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366: 293–300
Reinges MH, Kaiser WA, Miersch WA, Vogel J, Reiser M (1995) Dynamic MRI of benign and malignant testicular lesions: preliminary observations. Eur Radiol 5:615–622
Schmidt B, Ackermann R, Strohmeyer T (1995) Molecular biology of testicular germ cell tumors: current status. J Mol Med 73:355–367
Schmoll HJ, Souchon R, Krege S et al. (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377–1399
Schnorr D, Loening SA, Weißbach L (Hrsg) (1995) Hodentumoren/ testis cancer. Blackwell, Berlin
Schölermann KH, Dettmann R, Hartmann M (1996) Die risikogesteuerte Hodentumornachsorge. Urologe A 35:326–330
Stomper PC, Fung CY, Socinski MA, Jochelson MS, Garnick MB, Richie JP (1987) Detection of retroperitoneal metastases in early-stage non-seminomatous testicular cancer: analysis of different CT-criteria. Am J Roentgenol 149: 1187–1190
Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M, Slamon D (1995) Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153:511–515
Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, Maase H von der (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 15:4448–4452
Weißbach L, Bamberg M, Schmoll HJ (1997) Interdisziplinäre Konsensuskonferenz zur „Diagnostik und Therapie von Hodentumoren“. Urologe 36:362–3
Weißbach L (1995) Organ-preserving surgery of malignant germ cell tumors. J Urol 153:90–93
Westergaard T, Olsen JH, Frisch M, Kroman N, Nielsen JW, Melbye M (1996) Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int J Cancer 29:627–631
Wittekind C, Klimpfinger M, Sobin LH (Hrsg) (2005) TNM-Atlas. Illustrierter Leitfaden zur TNM/pTNM-Klassifikation maligner Tumoren, 5. Aufl. Springer, Berlin Heidelberg New York
Wittekind C, Meyer HJ, Bootz F (Hrsg) (2002) UICC: TNM-Klassifikation maligner Tumoren, 6. Aufl. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kreft, B., Albers, P. (2008). Hodentumoren. In: Layer, G., van Kaick, G., Delorme, S. (eds) Radiologische Diagnostik in der Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-29319-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-29319-4_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29318-7
Online ISBN: 978-3-540-29319-4
eBook Packages: Medicine (German Language)